Founded in 2013, Abyrx develops, manufactures, and provides specialty biosurgical products for use during surgical procedures. Abyrx's products are protected by over forty issued and pending patents covering a broad range of compositions and methods.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/08/16 | $10,000,000 |
BB Biotech Ventures Canaan Partners MedEdge | undisclosed |
